Vanda Pharmaceuticals
VNDA
#7445
Rank
A$0.59 B
Marketcap
A$10.05
Share price
-2.95%
Change (1 day)
37.72%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$59.16 Million a decrease over its 2023 earnings that were of -A$20.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion217.99%
2024 -A$59.16 Million191.43%
2023 -A$20.3 Million-320.45%
2022 A$9.2 M-84.99%
2021 A$61.34 M54.8%
2020 A$39.63 M19.42%
2019 A$33.18 M4.93%
2018 A$31.62 M-228.6%
2017 -A$24.6 Million-8.98%
2016 -A$27.02 Million-53.79%
2015 -A$58.47 Million-30.18%
2014 -A$83.74 Million173.08%
2013 -A$30.67 Million-25.33%
2012 -A$41.07 Million163.61%
2011 -A$15.58 Million-221.15%
2010 A$12.85 M-124.53%
2009 -A$52.43 Million-29.44%
2008 -A$74.3 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$95.61 Million170.55%
2005 -A$35.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.81 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.79 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.82 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.43 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.62 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.09 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA